Paper · 19903845
Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase.
Pang H and 11 others. Cancer Res, 2009. Cited by 74 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase. Papers, record 19903845. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19903845
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cell Movement | Major topic |
| Mutation | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Animals | |
| Catalytic Domain | |
| Cattle | |
| Cell Line, Tumor | |
| Class I Phosphatidylinositol 3-Kinases | |
| Female | |
| Humans | |
| Lung Neoplasms | |
| Mice | |
| Protein Structure, Secondary | |
| Protein Subunits |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA100324 | NCI NIH HHS | United States | P01CA100324 | PubMed and NIH | NIH RePORTER |
| R01 GM055692 | NIGMS NIH HHS | United States | R01GM055692 | PubMed and NIH | NIH RePORTER |
| R01 CA113395 | NCI NIH HHS | United States | R01CA113395 | PubMed and NIH | NIH RePORTER |
| GM55692 | NIGMS NIH HHS | United States | R01GM055692 | PubMed and NIH | NIH RePORTER |
| CA113395 | NCI NIH HHS | United States | R01CA113395 | PubMed and NIH | NIH RePORTER |
| P01 CA 100324 | NCI NIH HHS | United States | P01CA100324 | PubMed and NIH | NIH RePORTER |
| P30 CA013330 | NCI NIH HHS | United States | P30CA013330 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,930,273 | Functional analysis of PIK3CA gene mutations in human colorectal cancer. | Cancer Res | 2005 | https://conductscience.org/library/papers/15930273 | PubMed |
| 2 | 18,084,252 | PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters. | Mod Pathol | 2008 | https://conductscience.org/library/papers/18084252 | PubMed |
| 3 | 17,888,630 | Interactions of Ras proteins with the plasma membrane and their roles in signaling. | Cell Signal | 2008 | https://conductscience.org/library/papers/17888630 | PubMed |
| 4 | 19,573,809 | AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19573809 | PubMed |
| 5 | 11,036,626 | Rho GTPases and cell migration: measurement of macrophage chemotaxis. | Methods Enzymol | 2000 | https://conductscience.org/library/papers/11036626 | PubMed |
| 6 | 17,452,630 | Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17452630 | PubMed |
| 7 | 16,926,057 | Regulation of the actin cytoskeleton in cancer cell migration and invasion. | Biochim Biophys Acta | 2007 | https://conductscience.org/library/papers/16926057 | PubMed |
| 8 | 15,647,370 | Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15647370 | PubMed |
| 9 | 18,224,685 | Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18224685 | PubMed |
| 10 | 9,276,291 | Analyzing chemotaxis using the Dunn direct-viewing chamber. | Methods Mol Biol | 1997 | https://conductscience.org/library/papers/9276291 | PubMed |
1 to 10 of 38
See all 38 referencesCited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,817,602 | Gene-specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: A prospective cohort study. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40817602 | PubMed |
| 40,641,158 | Prevalence of HPV Infection Among Chinese Males With HPV-Related Diseases: A Systematic Review and Meta-Analysis. | J Med Virol | 2025 | https://conductscience.org/library/papers/40641158 | PubMed |
| 39,810,024 | Decoding the functional impact of the cancer genome through protein-protein interactions. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/39810024 | PubMed |
| 39,369,580 | The PIK3CA gene and its pivotal role in tumor tropism of triple-negative breast cancer. | Transl Oncol | 2024 | https://conductscience.org/library/papers/39369580 | PubMed |
| 38,466,449 | PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38466449 | PubMed |
| 37,047,566 | PI4P-Containing Vesicles from Golgi Contribute to Mitochondrial Division by Coordinating with Polymerized Actin. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047566 | PubMed |
| 36,069,825 | A New View of Activating Mutations in Cancer. | Cancer Res | 2022 | https://conductscience.org/library/papers/36069825 | PubMed |
| 35,418,124 | Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer. | Nat Commun | 2022 | https://conductscience.org/library/papers/35418124 | PubMed |
| 35,050,709 | Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression. | JCO Precis Oncol | 2022 | https://conductscience.org/library/papers/35050709 | PubMed |
| 34,990,021 | PIP3 abundance overcomes PI3K signaling selectivity in invadopodia. | FEBS Lett | 2022 | https://conductscience.org/library/papers/34990021 | PubMed |
1 to 10 of 59
See all 59 cited byGenes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| EGF | 1,950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| ERVK-15 | 100,616,443 | PubTator's text mining | https://conductscience.org/library/genes/100616443 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MAPK1 | 5,594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MYC | 4,609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PDK1 | 5,163 | PubTator's text mining | https://conductscience.org/library/genes/5163 | NCBI Gene |
| PIK3CA | 5,290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| PIK3CB | 5,291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
1 to 10 of 17
See all 17 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19903845
GET https://conductscience.org/api/papers/v1/19903845/references?page=2